MassDevelopment
42
535K
41
1.68
6
0.02
- Stages of investment
- Areas of investment
Summary
In 1998 was created MassDevelopment, which is appeared as VC.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the MassDevelopment, startups are often financed by Think.Health, Life Science Angels, LRVHealth. In the next rounds fund is usually obtained by RKS Ventures, Material Impact Fund, LaunchCapital.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline First Light Diagnostics, Amastan Technologies
The average startup value when the investment from MassDevelopment is 1-5 millions dollars. The common things for fund are deals in the range of 1 - 5 millions dollars. Considering the real fund results, this VC is 60 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018.
Investments analytics
Analytics
- Total investments
- 42
- Lead investments
- 6
- Rounds per year
- 1.68
- Follow on index
- 0.02
- Investments by industry
- Health Care (30)
- Hospital (12)
- Medical (10)
- Non Profit (10)
- Dental (5) Show 37 more
- Investments by region
-
- United States (41)
- France (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 44
- Avg. valuation at time of investment
- 73K
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.